Articles - 1ktl mentioned but not cited (4)
- Single-Nucleotide Polymorphisms (SNP) Mining and Their Effect on the Tridimensional Protein Structure Prediction in a Set of Immunity-Related Expressed Sequence Tags (EST) in Atlantic Salmon (Salmo salar). Vallejos-Vidal E, Reyes-Cerpa S, Rivas-Pardo JA, Maisey K, Yáñez JM, Valenzuela H, Cea PA, Castro-Fernandez V, Tort L, Sandino AM, Imarai M, Reyes-López FE. Front Genet 10 1406 (2019)
- Nonameric Peptide Orchestrates Signal Transduction in the Activating HLA-E/NKG2C/CD94 Immune Complex as Revealed by All-Atom Simulations. Prašnikar E, Perdih A, Borišek J. Int J Mol Sci 22 6670 (2021)
- All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric Peptide. Prašnikar E, Perdih A, Borišek J. J Chem Inf Model 61 3593-3603 (2021)
- What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes. Prašnikar E, Perdih A, Borišek J. Front Pharmacol 13 925427 (2022)
Reviews citing this publication (48)
- MHC class Ib molecules bridge innate and acquired immunity. Rodgers JR, Cook RG. Nat Rev Immunol 5 459-471 (2005)
- The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Adams EJ, Luoma AM. Annu Rev Immunol 31 529-561 (2013)
- Genetic modification of pigs as organ donors for xenotransplantation. Klymiuk N, Aigner B, Brem G, Wolf E. Mol Reprod Dev 77 209-221 (2010)
- The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE. Immunol Res 35 263-278 (2006)
- The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Sullivan LC, Clements CS, Rossjohn J, Brooks AG. Tissue Antigens 72 415-424 (2008)
- Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? Crux NB, Elahi S. Front Immunol 8 832 (2017)
- Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. López-Botet M, Angulo A, Gumá M. Tissue Antigens 63 195-203 (2004)
- A bird's eye view of NK cell receptor interactions with their MHC class I ligands. Saunders PM, Vivian JP, O'Connor GM, Sullivan LC, Pymm P, Rossjohn J, Brooks AG. Immunol Rev 267 148-166 (2015)
- Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. Hoare HL, Sullivan LC, Clements CS, Ely LK, Beddoe T, Henderson KN, Lin J, Reid HH, Brooks AG, Rossjohn J. J Mol Biol 377 1297-1303 (2008)
- The involvement of HLA-E and -F in pregnancy. Ishitani A, Sageshima N, Hatake K. J Reprod Immunol 69 101-113 (2006)
- HLA-G modulates immune responses by diverse receptor interactions. Hofmeister V, Weiss EH. Semin Cancer Biol 13 317-323 (2003)
- Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases. Joosten SA, Sullivan LC, Ottenhoff TH. J Immunol Res 2016 2695396 (2016)
- Clinical and immunological significance of HLA-E in stem cell transplantation and cancer. Wieten L, Mahaweni NM, Voorter CE, Bos GM, Tilanus MG. Tissue Antigens 84 523-535 (2014)
- Clinical significance of the HLA-E and CD94/NKG2 interaction. Iwaszko M, Bogunia-Kubik K. Arch Immunol Ther Exp (Warsz) 59 353-367 (2011)
- Genetics of Natural Killer Cells in Human Health, Disease, and Survival. Parham P, Guethlein LA. Annu Rev Immunol 36 519-548 (2018)
- Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Dahl M, Hviid TV. Hum Reprod Update 18 92-109 (2012)
- Structural studies on HLA-G: implications for ligand and receptor binding. Clements CS, Kjer-Nielsen L, McCluskey J, Rossjohn J. Hum Immunol 68 220-226 (2007)
- The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress. van Hall T, Oliveira CC, Joosten SA, Ottenhoff TH. Microbes Infect 12 910-918 (2010)
- HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia. Djurisic S, Hviid TV. Front Immunol 5 652 (2014)
- HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis. Meuleman T, Lashley LE, Dekkers OM, van Lith JM, Claas FH, Bloemenkamp KW. Hum Immunol 76 362-373 (2015)
- Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses. Geluk A, van Meijgaarden KE, Joosten SA, Commandeur S, Ottenhoff TH. Front Immunol 5 256 (2014)
- Harnessing donor unrestricted T-cells for new vaccines against tuberculosis. Joosten SA, Ottenhoff THM, Lewinsohn DM, Hoft DF, Moody DB, Seshadri C, Collaboration for Tuberculosis Vaccine Discovery - Donor-Unrestricted T-cells Working Group, Bill and Melinda Gates Foundation. Vaccine 37 3022-3030 (2019)
- HLA-E: a novel player for histocompatibility. Kraemer T, Blasczyk R, Bade-Doeding C. J Immunol Res 2014 352160 (2014)
- The role of human leukocyte antigen E and G in HIV infection. Tripathi P, Agrawal S. AIDS 21 1395-1404 (2007)
- Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A. Mahaweni NM, Ehlers FAI, Bos GMJ, Wieten L. Front Immunol 9 2848 (2018)
- HLA class Ib in pregnancy and pregnancy-related disorders. Persson G, Melsted WN, Nilsson LL, Hviid TVF. Immunogenetics 69 581-595 (2017)
- NK cells, innate immunity and hepatitis C infection after liver transplantation. Nellore A, Fishman JA. Clin Infect Dis 52 369-377 (2011)
- HLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle? Rölle A, Jäger D, Momburg F. Front Immunol 9 2410 (2018)
- Expression of MHC class I-related molecules MICA, HLA-E and EPCR shape endothelial cells with unique functions in innate and adaptive immunity. Gavlovsky PJ, Tonnerre P, Guitton C, Charreau B. Hum Immunol 77 1084-1091 (2016)
- HLA-E: exploiting pathogen-host interactions for vaccine development. Sharpe HR, Bowyer G, Brackenridge S, Lambe T. Clin Exp Immunol 196 167-177 (2019)
- Dimorphism of HLA-E and its Disease Association. Kanevskiy L, Erokhina S, Kobyzeva P, Streltsova M, Sapozhnikov A, Kovalenko E. Int J Mol Sci 20 E5496 (2019)
- What the HLA-I!-Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes. Wyatt RC, Lanzoni G, Russell MA, Gerling I, Richardson SJ. Curr Diab Rep 19 159 (2019)
- The Role of NK Cells in Pig-to-Human Xenotransplantation. Puga Yung G, Schneider MKJ, Seebach JD. J Immunol Res 2017 4627384 (2017)
- Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection. Hölzemer A, Garcia-Beltran WF, Altfeld M. Front Immunol 8 1496 (2017)
- Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation? Hosseini E, Schwarer AP, Ghasemzadeh M. Exp Hematol 43 149-157 (2015)
- Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection. Njiomegnie GF, Read SA, Fewings N, George J, McKay F, Ahlenstiel G. J Clin Med 9 E1030 (2020)
- The role of donor-unrestricted T-cells, innate lymphoid cells, and NK cells in anti-mycobacterial immunity. Ruibal P, Voogd L, Joosten SA, Ottenhoff THM. Immunol Rev 301 30-47 (2021)
- Enhancing Natural Killer and CD8+ T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8+ T Cells with HLA-E Monospecific Monoclonal Antibodies. Ravindranath MH, Filippone EJ, Devarajan A, Asgharzadeh S. Monoclon Antib Immunodiagn Immunother 38 38-59 (2019)
- Human leukocyte antigen E in human cytomegalovirus infection: friend or foe? Gong F, Song S, Lv G, Pan Y, Zhang D, Jiang H. Acta Biochim Biophys Sin (Shanghai) 44 551-554 (2012)
- Antigen presentation by MHC-E: a putative target for vaccination? Voogd L, Ruibal P, Ottenhoff THM, Joosten SA. Trends Immunol 43 355-365 (2022)
- Engineering soluble T-cell receptors for therapy. Robinson RA, McMurran C, McCully ML, Cole DK. FEBS J 288 6159-6173 (2021)
- European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment. Würfel FM, Winterhalter C, Trenkwalder P, Wirtz RM, Würfel W. Int J Mol Sci 20 E1830 (2019)
- HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation. Duygu B, Olieslagers TI, Groeneweg M, Voorter CEM, Wieten L. Front Immunol 12 680480 (2021)
- Human Leukocyte Antigens in Pregnancy and Preeclampsia. Aisagbonhi O, Morris GP. Front Genet 13 884275 (2022)
- Current Trends in Neoantigen-Based Cancer Vaccines. Ho SY, Chang CM, Liao HN, Chou WH, Guo CL, Yen Y, Nakamura Y, Chang WC. Pharmaceuticals (Basel) 16 392 (2023)
- MR1- and HLA-E-Dependent Antigen Presentation of Mycobacterium tuberculosis. Kim SJ, Karamooz E. Int J Mol Sci 23 14412 (2022)
- Towards Clinical Translation of CD8+ Regulatory T Cells Restricted by Non-Classical Major Histocompatibility Complex Ib Molecules. Wasnik S, Baylink DJ, Leavenworth J, Liu C, Bi H, Tang X. Int J Mol Sci 20 E4829 (2019)
- [Natural killer lymphocyte activation in response to stress]. Toubert A, Dulphy N, Tieng V, Tamouza R, Charron D. Transfus Clin Biol 10 109-112 (2003)
Articles citing this publication (144)
- Activation of NK cells by an endocytosed receptor for soluble HLA-G. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. PLoS Biol 4 e9 (2006)
- Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E. Hansen SG, Wu HL, Burwitz BJ, Hughes CM, Hammond KB, Ventura AB, Reed JS, Gilbride RM, Ainslie E, Morrow DW, Ford JC, Selseth AN, Pathak R, Malouli D, Legasse AW, Axthelm MK, Nelson JA, Gillespie GM, Walters LC, Brackenridge S, Sharpe HR, López CA, Früh K, Korber BT, McMichael AJ, Gnanakaran S, Sacha JB, Picker LJ. Science 351 714-720 (2016)
- Structural basis for NKG2A/CD94 recognition of HLA-E. Kaiser BK, Pizarro JC, Kerns J, Strong RK. Proc Natl Acad Sci U S A 105 6696-6701 (2008)
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes. Gooden M, Lampen M, Jordanova ES, Jordanova ES, Leffers N, Trimbos JB, van der Burg SH, Nijman H, van Hall T. Proc Natl Acad Sci U S A 108 10656-10661 (2011)
- Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. Kaiser BK, Barahmand-Pour F, Paulsene W, Medley S, Geraghty DE, Strong RK. J Immunol 174 2878-2884 (2005)
- Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, Drijfhout JW, Flower DR, Hanekom WA, Klein MR, Ottenhoff TH. PLoS Pathog 6 e1000782 (2010)
- Class I HLA haplotypes form two schools that educate NK cells in different ways. Horowitz A, Djaoud Z, Nemat-Gorgani N, Blokhuis J, Hilton HG, Béziat V, Malmberg KJ, Norman PJ, Guethlein LA, Parham P. Sci Immunol 1 eaag1672 (2016)
- Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Ramsuran V, Naranbhai V, Horowitz A, Qi Y, Martin MP, Yuki Y, Gao X, Walker-Sperling V, Del Prete GQ, Schneider DK, Lifson JD, Fellay J, Deeks SG, Martin JN, Goedert JJ, Wolinsky SM, Michael NL, Kirk GD, Buchbinder S, Haas D, Ndung'u T, Goulder P, Parham P, Walker BD, Carlson JM, Carrington M. Science 359 86-90 (2018)
- Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Clements CS, Kjer-Nielsen L, Kostenko L, Hoare HL, Dunstone MA, Moses E, Freed K, Brooks AG, Rossjohn J, McCluskey J. Proc Natl Acad Sci U S A 102 3360-3365 (2005)
- HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Weiss EH, Lilienfeld BG, Müller S, Müller E, Herbach N, Kessler B, Wanke R, Schwinzer R, Seebach JD, Wolf E, Brem G. Transplantation 87 35-43 (2009)
- Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, Ely LK, Beddoe T, Falco M, Kjer-Nielsen L, Reid HH, McCluskey J, Moretta L, Rossjohn J, Brooks AG. Nat Immunol 7 256-264 (2006)
- The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, Laban S, Drijfhout JW, van der Burg SH, Offringa R, van Hall T. J Exp Med 207 207-221 (2010)
- Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. van Meijgaarden KE, Haks MC, Caccamo N, Dieli F, Ottenhoff TH, Joosten SA. PLoS Pathog 11 e1004671 (2015)
- Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. Heatley SL, Pietra G, Lin J, Widjaja JML, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG. J Biol Chem 288 8679-8690 (2013)
- NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Muntasell A, López-Montañés M, Vera A, Heredia G, Romo N, Peñafiel J, Moraru M, Vila J, Vilches C, López-Botet M. Eur J Immunol 43 3268-3278 (2013)
- Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Dulberger CL, McMurtrey CP, Hölzemer A, Neu KE, Liu V, Steinbach AM, Garcia-Beltran WF, Sulak M, Jabri B, Lynch VJ, Altfeld M, Hildebrand WH, Adams EJ. Immunity 46 1018-1029.e7 (2017)
- Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, McSharry BP, Wang EC, Cuff S, Martoglio B, Davison AJ, Braud VM, Wilkinson GW. J Immunol 188 2794-2804 (2012)
- HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. Lee N, Geraghty DE. J Immunol 171 5264-5271 (2003)
- HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading. Forte P, Baumann BC, Weiss EH, Seebach JD. Am J Transplant 5 2085-2093 (2005)
- NKG2C deletion is a risk factor of HIV infection. Thomas R, Low HZ, Kniesch K, Jacobs R, Schmidt RE, Witte T. AIDS Res Hum Retroviruses 28 844-851 (2012)
- Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nagarajan NA, Gonzalez F, Shastri N. Nat Immunol 13 579-586 (2012)
- NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Haas P, Loiseau P, Tamouza R, Cayuela JM, Moins-Teisserenc H, Busson M, Henry G, Falk CS, Charron D, Socié G, Toubert A, Dulphy N. Blood 117 1021-1029 (2011)
- Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Vietzen H, Zoufaly A, Traugott M, Aberle J, Aberle SW, Puchhammer-Stöckl E. Genet Med 23 963-967 (2021)
- Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells. Lo Monaco E, Tremante E, Cerboni C, Melucci E, Sibilio L, Zingoni A, Nicotra MR, Natali PG, Giacomini P. Neoplasia 13 822-830 (2011)
- HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES. Tissue Antigens 69 139-144 (2007)
- Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant. Jagessar SA, Heijmans N, Blezer EL, Bauer J, Blokhuis JH, Wubben JA, Drijfhout JW, van den Elsen PJ, Laman JD, Hart BA. Eur J Immunol 42 217-227 (2012)
- The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch. Celik AA, Kraemer T, Huyton T, Blasczyk R, Bade-Döding C. Immunogenetics 68 29-41 (2016)
- HLA-E and immunobiology of pregnancy. Tripathi P, Naik S, Agrawal S. Tissue Antigens 67 207-213 (2006)
- Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices. Di Marco M, Schuster H, Backert L, Ghosh M, Rammensee HG, Stevanović S. J Immunol 199 2639-2651 (2017)
- HLA-E polymorphism in patients with nasopharyngeal carcinoma. Hirankarn N, Kimkong I, Mutirangura A. Tissue Antigens 64 588-592 (2004)
- Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. Walters LC, Harlos K, Brackenridge S, Rozbesky D, Barrett JR, Jain V, Walter TS, O'Callaghan CA, Borrow P, Toebes M, Hansen SG, Sacha JB, Abdulhaqq S, Greene JM, Früh K, Marshall E, Picker LJ, Jones EY, McMichael AJ, Gillespie GM. Nat Commun 9 3137 (2018)
- HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes. Pyo CW, Williams LM, Moore Y, Hyodo H, Li SS, Zhao LP, Sageshima N, Ishitani A, Geraghty DE. Immunogenetics 58 241-251 (2006)
- Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation. Tamouza R, Busson M, Rocha V, Fortier C, Haddad Y, Brun M, Boukouaci W, Bleux H, Socié G, Krishnamoorthy R, Toubert A, Gluckman E, Charron D. Transplantation 82 1436-1440 (2006)
- HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome. Kraemer T, Celik AA, Huyton T, Kunze-Schumacher H, Blasczyk R, Bade-Döding C. Stem Cells Int 2015 346714 (2015)
- An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Crew MD, Cannon MJ, Phanavanh B, Garcia-Borges CN. Mol Immunol 42 1205-1214 (2005)
- HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Palmisano GL, Contardi E, Morabito A, Gargaglione V, Ferrara GB, Pistillo MP. Hum Immunol 66 1-12 (2005)
- Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Am J Obstet Gynecol 197 255.e1-5 (2007)
- Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Tamouza R, Rocha V, Busson M, Fortier C, El Sherbini SM, Esperou H, Filion A, Socié G, Dulphy N, Krishnamoorthy R, Toubert A, Gluckman E, Charron D. Transplantation 80 140-144 (2005)
- Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. Hülsmeyer M, Welfle K, Pöhlmann T, Misselwitz R, Alexiev U, Welfle H, Saenger W, Uchanska-Ziegler B, Ziegler A. J Mol Biol 346 1367-1379 (2005)
- Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation. Danzer M, Polin H, Pröll J, Haunschmid R, Hofer K, Stabentheiner S, Hackl C, Kasparu H, König J, Hauser H, Binder M, Weiss R, Gabriel C, Krieger O. Transplantation 88 528-532 (2009)
- A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b. Zeng L, Sullivan LC, Vivian JP, Walpole NG, Harpur CM, Rossjohn J, Clements CS, Brooks AG. J Immunol 188 302-310 (2012)
- Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J. Clin Exp Immunol 174 414-423 (2013)
- The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques. Wu HL, Wiseman RW, Hughes CM, Webb GM, Abdulhaqq SA, Bimber BN, Hammond KB, Reed JS, Gao L, Burwitz BJ, Greene JM, Ferrer F, Legasse AW, Axthelm MK, Park BS, Brackenridge S, Maness NJ, McMichael AJ, Picker LJ, O'Connor DH, Hansen SG, Sacha JB. J Immunol 200 49-60 (2018)
- MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection. Bian Y, Shang S, Siddiqui S, Zhao J, Joosten SA, Ottenhoff THM, Cantor H, Wang CR. PLoS Pathog 13 e1006384 (2017)
- Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations. Le Page ME, Goodridge JP, John E, Christiansen FT, Witt CS. J Immunol 192 732-740 (2014)
- Letter Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors. Ludajic K, Rosenmayr A, Faé I, Fischer GF, Balavarca Y, Bickeböller H, Kalhs P, Greinix HT. Transplantation 88 1227-1228 (2009)
- HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition. Jouand N, Bressollette-Bodin C, Gérard N, Giral M, Guérif P, Rodallec A, Oger R, Parrot T, Allard M, Cesbron-Gautier A, Gervois N, Charreau B. PLoS Pathog 14 e1007041 (2018)
- Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes. Ramsuran V, Hernández-Sanchez PG, O'hUigin C, Sharma G, Spence N, Augusto DG, Gao X, García-Sepúlveda CA, Kaur G, Mehra NK, Carrington M. J Immunol 198 2320-2329 (2017)
- HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Wagner B, da Silva Nardi F, Schramm S, Kraemer T, Celik AA, Dürig J, Horn PA, Dührsen U, Nückel H, Rebmann V. Cancer 123 814-823 (2017)
- HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation. Allard M, Tonnerre P, Nedellec S, Oger R, Morice A, Guilloux Y, Houssaint E, Charreau B, Gervois N. PLoS One 7 e50951 (2012)
- HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Tamouza R, Busson M, Fortier C, Diagne I, Diallo D, Sloma I, Contouris H, Krishnamoorthy R, Labie D, Girot R, Charron D. Hum Immunol 68 849-853 (2007)
- Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. Petersdorf EW, Carrington M, O'hUigin C, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Maiers MJ, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P, International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Lancet Haematol 7 e50-e60 (2020)
- HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load. Merino AM, Song W, He D, Mulenga J, Allen S, Hunter E, Tang J, Kaslow RA. J Infect Dis 205 1797-1805 (2012)
- T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. McMurtrey C, Harriff MJ, Swarbrick GM, Duncan A, Cansler M, Null M, Bardet W, Jackson KW, Lewinsohn DA, Hildebrand W, Lewinsohn DM. PLoS One 12 e0188288 (2017)
- Ethnic variability in human leukocyte antigen-E haplotypes. Antoun A, Jobson S, Cook M, Moss P, Briggs D. Tissue Antigens 73 39-45 (2009)
- Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Winkler K, Winter A, Rueckert C, Uchanska-Ziegler B, Alexiev U. Biophys J 93 2743-2755 (2007)
- Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS. Tissue Antigens 70 307-313 (2007)
- HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia. Paladini F, Belfiore F, Cocco E, Carcassi C, Cauli A, Vacca A, Fiorillo MT, Mathieu A, Cascino I, Sorrentino R. Arthritis Res Ther 11 R171 (2009)
- Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, Mathieu A, Sorrentino R. Arthritis Rheum 56 2640-2651 (2007)
- Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer. Zhen ZJ, Ling JY, Cai Y, Luo WB, He YJ. Med Oncol 30 482 (2013)
- Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy. Iwaszko M, Świerkot J, Kolossa K, Jeka S, Wiland P, Bogunia-Kubik K. Clin Exp Immunol 182 270-277 (2015)
- Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype. Lauterbach N, Wieten L, Popeijus HE, Vanderlocht J, van Zon PM, Voorter CE, Tilanus MG. Tissue Antigens 85 242-251 (2015)
- Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Ulbrecht M, Maier S, Hofmeister V, Falk CS, Brooks AG, McMaster MT, Weiss EH. Hum Immunol 65 200-208 (2004)
- Worldwide HLA-E nucleotide and haplotype variability reveals a conserved gene for coding and 3' untranslated regions. Felício LP, Porto IO, Mendes-Junior CT, Veiga-Castelli LC, Santos KE, Vianello-Brondani RP, Sabbagh A, Moreau P, Donadi EA, Castelli EC. Tissue Antigens 83 82-93 (2014)
- Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression. van Stigt Thans T, Akko JI, Niehrs A, Garcia-Beltran WF, Richert L, Stürzel CM, Ford CT, Li H, Ochsenbauer C, Kappes JC, Hahn BH, Kirchhoff F, Martrus G, Sauter D, Altfeld M, Hölzemer A. J Virol 93 e00719-19 (2019)
- Identification of novel HIV-1-derived HLA-E-binding peptides. Hannoun Z, Lin Z, Brackenridge S, Kuse N, Akahoshi T, Borthwick N, McMichael A, Murakoshi H, Takiguchi M, Hanke T. Immunol Lett 202 65-72 (2018)
- Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients. Ravindranath MH, Pham T, Ozawa M, Terasaki PI. Int Immunol 24 43-57 (2012)
- Association between HLA-E *0101 homozygosity and recurrent miscarriage in Egyptian women. Mosaad YM, Abdel-Dayem Y, El-Deek BS, El-Sherbini SM. Scand J Immunol 74 205-209 (2011)
- Characterization of HLA-E polymorphism in four distinct populations in Mainland China. Liu XX, Pan FH, Tian W. Tissue Antigens 80 26-35 (2012)
- Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells. Djaoud Z, Riou R, Gavlovsky PJ, Mehlal S, Bressollette C, Gérard N, Gagne K, Charreau B, Retière C. J Innate Immun 8 374-385 (2016)
- HLA-E polymorphisms in hematopoietic stem cell transplantation. Fürst D, Bindja J, Arnold R, Herr W, Schwerdtfeger R, Müller CH, Recker K, Schrezenmeier H, Mytilineos J. Tissue Antigens 79 287-290 (2012)
- HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris. Bhanusali DG, Sachdev A, Rahmanian A, Gerlach JA, Tong JC, Seiffert-Sinha K, Sinha AA. Exp Dermatol 22 108-112 (2013)
- Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer. Zheng H, Lu R, Xie S, Wen X, Wang H, Gao X, Guo L. Cancer Sci 106 522-528 (2015)
- Non-classical HLA-E gene variability in Brazilians: a nearly invariable locus surrounded by the most variable genes in the human genome. Veiga-Castelli LC, Castelli EC, Mendes CT, da Silva WA, Faucher MC, Beauchemin K, Roger M, Moreau P, Donadi EA. Tissue Antigens 79 15-24 (2012)
- Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants. Lafont BA, Buckler-White A, Plishka R, Buckler C, Martin MA. Immunogenetics 56 142-154 (2004)
- Distribution of HLA-G extended haplotypes and one HLA-E polymorphism in a large-scale study of mother-child dyads with and without severe preeclampsia and eclampsia. Nilsson LL, Djurisic S, Andersen AM, Melbye M, Bjerre D, Ferrero-Miliani L, Hackmon R, Geraghty DE, Hviid TV. HLA 88 172-186 (2016)
- Increased HLA-E expression in white matter lesions in multiple sclerosis. Durrenberger PF, Webb LV, Sim MJ, Nicholas RS, Altmann DM, Boyton RJ. Immunology 137 317-325 (2012)
- HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients. Pannemans K, Broux B, Goris A, Dubois B, Broekmans T, Van Wijmeersch B, Geraghty D, Stinissen P, Hellings N. Mult Scler 20 790-801 (2014)
- Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers. Ravindranath MH, Jucaud V, Ferrone S. J Immunol Methods 450 73-80 (2017)
- Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts. Choi JY, Eskandari SK, Cai S, Sulkaj I, Assaker JP, Allos H, AlHaddad J, Muhsin SA, Alhussain E, Mansouri A, Yeung MY, Seelen MAJ, Kim HJ, Cantor H, Azzi JR. Proc Natl Acad Sci U S A 117 6042-6046 (2020)
- The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. Walpole NG, Kjer-Nielsen L, Kostenko L, McCluskey J, Brooks AG, Rossjohn J, Clements CS. J Mol Biol 397 467-480 (2010)
- A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors. Sullivan LC, Walpole NG, Farenc C, Pietra G, Sum MJW, Clements CS, Lee EJ, Beddoe T, Falco M, Mingari MC, Moretta L, Gras S, Rossjohn J, Brooks AG. J Biol Chem 292 21149-21158 (2017)
- Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells. Sasaki T, Kanaseki T, Shionoya Y, Tokita S, Miyamoto S, Saka E, Kochin V, Takasawa A, Hirohashi Y, Tamura Y, Miyazaki A, Torigoe T, Hiratsuka H, Sato N. Eur J Immunol 46 929-940 (2016)
- Natural polymorphisms in Tap2 influence negative selection and CD4∶CD8 lineage commitment in the rat. Tuncel J, Haag S, Yau AC, Norin U, Baud A, Lönnblom E, Maratou K, Ytterberg AJ, Ekman D, Thordardottir S, Johannesson M, Gillett A, EURATRANS Consortium, Stridh P, Jagodic M, Olsson T, Fernández-Teruel A, Zubarev RA, Mott R, Aitman TJ, Flint J, Holmdahl R. PLoS Genet 10 e1004151 (2014)
- UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients. Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L, Lebrette ME, Schrive MH, Roncin L, Taupin JL, Déchanet-Merville J, Fleury H, Lafon ME. Transplantation 86 826-835 (2008)
- Clinical significance of HLA-E genotype and surface/soluble expression levels between healthy individuals and patients with acute leukemia. Xu YP, Wieten L, Wang SX, Cai Y, Olieslagers T, Zhang L, He LM, Tilanus MGJ, Hong WX, Hong WX. Leuk Lymphoma 60 208-215 (2019)
- HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. Guzmán-Fulgencio M, Berenguer J, Rallón N, Fernández-Rodríguez A, Miralles P, Soriano V, Jiménez-Sousa MA, Cosín J, Medrano J, García-Álvarez M, López JC, Benito JM, Resino S. AIDS 27 1231-1238 (2013)
- Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Vigón L, Luna A, Galán M, Rodríguez-Mora S, Fuertes D, Mateos E, Piris-Villaespesa M, Bautista G, San José E, Rivera-Torres J, Steegmann JL, de Ory F, Pérez-Olmeda M, Alcamí J, Planelles V, López-Huertas MR, García-Gutiérrez V, Coiras M. J Clin Med 10 E42 (2020)
- Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues. Ruibal P, Franken KLMC, van Meijgaarden KE, van Loon JJF, van der Steen D, Heemskerk MHM, Ottenhoff THM, Joosten SA. J Immunol 205 2861-2872 (2020)
- Significance of association of HLA-C and HLA-E with psoriatic arthritis. Sokolik R, Gębura K, Iwaszko M, Świerkot J, Korman L, Wiland P, Bogunia-Kubik K. Hum Immunol 75 1188-1191 (2014)
- Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients. Ravindranath MH, Selvan SR, Terasaki PI. J Immunotoxicol 9 282-291 (2012)
- HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant. Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. Cells 8 E847 (2019)
- HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients. Zidi I, Laaribi AB, Bortolotti D, Belhadj M, Mehri A, Yahia HB, Babay W, Chaouch H, Zidi N, Letaief A, Yacoub S, Boukadida J, Di Luca D, Hannachi N, Rizzo R. HLA 87 153-159 (2016)
- Human leukocyte antigen (HLA-F) polymorphism is associated with chronic HBV infection. Laaribi AB, Hannachi N, Ben Yahia H, Marzouk M, Mehri A, Belhadj M, Yacoub S, Letaief A, Ouzari HI, Boudabous A, Boukadida J, Rizzo R, Zidi I. 3 Biotech 8 49 (2018)
- Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-E and HLA-F. Santos MR, Couto AR, Foroni I, Bettencourt BF, Li Z, Meneses R, Wheeler L, Pereira J, Pimentel-Santos F, Fonseca JE, Alves H, Martinho A, Lima M, Brown MA, Bruges-Armas J. RMD Open 4 e000677 (2018)
- Release of pig leukocytes and reduced human NK cell recruitment during ex vivo perfusion of HLA-E/human CD46 double-transgenic pig limbs with human blood. Puga Yung G, Bongoni AK, Pradier A, Madelon N, Papaserafeim M, Sfriso R, Ayares DL, Wolf E, Klymiuk N, Bähr A, Constantinescu MA, Voegelin E, Kiermeir D, Jenni H, Rieben R, Seebach JD. Xenotransplantation 25 (2018)
- A high-throughput Taqman approach for the discrimination of HLA-E alleles. Paquay MM, Schellekens J, Tilanus MG. Tissue Antigens 74 514-519 (2009)
- Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis. Vietzen H, Rückert T, Hartenberger S, Honsig C, Jaksch P, Geleff S, Hammer Q, Romagnani C, Segura-Wang M, Puchhammer-Stöckl E. mBio 12 e02996-20 (2021)
- HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients. Mossallam GI, Fattah RA, El-Haddad A, Mahmoud HK. Hum Immunol 76 161-165 (2015)
- HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues. Hò GT, Heinen FJ, Huyton T, Blasczyk R, Bade-Döding C. Immunogenetics 71 353-360 (2019)
- Involvement of position-147 for HLA-E expression. Matsunami K, Kusama T, Okura E, Shirakura R, Fukuzawa M, Miyagawa S. Biochem Biophys Res Commun 347 692-697 (2006)
- New insights in HLA-E polymorphism by refined analysis of the full-length gene. Olieslagers TI, Voorter CE, Groeneweg M, Xu Y, Wieten L, Tilanus MG. HLA 89 143-149 (2017)
- Glances in Immunology of HIV and HCV Infection. Quaranta MG, Mattioli B, Vella S. Adv Virol 2012 434036 (2012)
- Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients. Tsamadou C, Fürst D, Vucinic V, Bunjes D, Neuchel C, Mytilineos D, Gramatzki M, Arnold R, Wagner EM, Einsele H, Müller C, Schrezenmeier H, Mytilineos J. Haematologica 102 1947-1955 (2017)
- Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians. Hassen E, Ghedira R, Ghandri N, Farhat K, Gabbouj S, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L. DNA Cell Biol 30 603-609 (2011)
- Association between HLA-E gene polymorphism and unexplained recurrent spontaneous abortion (RSA) in Iranian women. Fotoohi M, Ghasemi N, Mirghanizadeh SA, Vakili M, Samadi M. Int J Reprod Biomed 14 477-482 (2016)
- HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. Martín P, Krsnik I, Navarro B, Provencio M, García JF, Bellas C, Vilches C, Gomez-Lozano N. PLoS One 10 e0135512 (2015)
- HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection. Bansal A, Gehre MN, Qin K, Sterrett S, Ali A, Dang Y, Abraham S, Costanzo MC, Venegas LA, Tang J, Manjunath N, Brockman MA, Yang OO, Kan-Mitchell J, Goepfert PA. J Clin Invest 131 148979 (2021)
- The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells. Zhang B, Wei H, Zheng X, Zhang J, Sun R, Tian Z. Peptides 26 405-412 (2005)
- Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia. Pump WC, Kraemer T, Huyton T, Hò GT, Blasczyk R, Bade-Doeding C. Int J Mol Sci 20 E1454 (2019)
- Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia. Tsamadou C, Fürst D, Wang T, He N, Lee SJ, Spellman SR, Fleischhauer K, Hsu KC, Paczesny S, Verneris MR, Schrezenmeier H, Mytilineos J. Biol Blood Marrow Transplant 25 2357-2365 (2019)
- Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis. Cauli A, Dessole G, Piga M, Angioni MM, Pinna S, Floris A, Congia M, Mascia E, Paladini F, Tedeschi V, Sorrentino R, Fiorillo MT, Mathieu A. RMD Open 4 e000597 (2018)
- HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma. Yang Y, Liu Z, Wang H, Zhang G. Front Oncol 11 670673 (2021)
- Is HLA-E a possible genetic marker relevant for natural conception? Gelmini GF, Costa CH, Nardi FD, Wowk PF, Mattar SB, Schuffner A, Bicalho MD, Roxo VM. Am J Reprod Immunol 76 439-442 (2016)
- Association of human leukocyte antigen E polymorphism with human cytomegalovirus reactivation in Chinese burn patients. Gong F, Ding L, Jiang D, Zhang C, Shen W, Pan Y. Acta Biochim Biophys Sin (Shanghai) 45 982-984 (2013)
- HLA-E diversity unfolded: Identification and characterization of 170 novel HLA-E alleles. Paech C, Albrecht V, Putke K, Schöfl G, Schöne B, Schmidt AH, Lange V, Klussmeier A. HLA 97 389-398 (2021)
- Letter Lack of association between HLA-E polymorphisms and transitional cell carcinoma of the bladder. Veiga-Castelli LC, de Paula Cruz AS, Inácio MM, Mendes-Junior CT, Vianello-Brondani R, Moreau P, Castelli EC, Donadi EA. Tissue Antigens 82 197-200 (2013)
- Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes. Walters LC, Rozbesky D, Harlos K, Quastel M, Sun H, Springer S, Rambo RP, Mohammed F, Jones EY, McMichael AJ, Gillespie GM. Cell Rep 39 110959 (2022)
- Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognition. Barber C, De Souza VA, Paterson RL, Martin-Urdiroz M, Mulakkal NC, Srikannathasan V, Connolly M, Phillips G, Foong-Leong T, Pengelly R, Karuppiah V, Grant T, Dembek M, Verma A, Gibbs-Howe D, Blicher TH, Knox A, Robinson RA, Cole DK, Leonard S. Eur J Immunol 52 618-632 (2022)
- Dissection of the NKG2C NK cell response against Puumala Orthohantavirus. Vietzen H, Hartenberger S, Aberle SW, Puchhammer-Stöckl E. PLoS Negl Trop Dis 15 e0010006 (2021)
- Establishment of optimized ELISA system specific for HLA-G in body fluids. Ouji-Sageshima N, Geraghty DE, Ishitani A, Hatake K, Ito T. HLA 88 293-299 (2016)
- Human Leukocyte Antigen-E Alleles are Associated with Hepatitis C Virus, Torque Teno Virus, and Toxoplasma Co-infections but are not Associated with Hepatitis B Virus, Hepatitis D Virus, and GB Virus C Co-infections in Human Immunodeficiency Virus Patients. Prasetyo AA, Dharmawan R, Raharjo I, Hudiyono. J Glob Infect Dis 8 75-81 (2016)
- Combination strategies to durably suppress HIV-1: Soluble T cell receptors. Wallace Z, Singh PK, Dorrell L. J Virus Erad 8 100082 (2022)
- Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome. Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Eikmans M, Vossen ACTM. Front Immunol 8 1904 (2017)
- Designing high affinity target-binding peptides to HLA-E: a key membrane antigen of multiple myeloma. Yang Y, Sun M, Yu Z, Liu J, Yan W, Liu Z, Wei M, Wang H. Aging (Albany NY) 12 20457-20470 (2020)
- Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3'-untranslated regions. Asenjo J, Moraru M, Al-Akioui-Sanz K, Altadill M, Muntasell A, López-Botet M, Vilches C. HLA 100 469-478 (2022)
- Establishment of Rapid Detection Methods for rs76971248 Related to Leukemia. Sun LY, Li Z, Wang SX, Chen H, Sun ZT, Peng L, He LM, Xu YP. Dis Markers 2022 9847708 (2022)
- HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses. Lin Z, Bashirova AA, Viard M, Garner L, Quastel M, Beiersdorfer M, Kasprzak WK, Akdag M, Yuki Y, Ojeda P, Das S, Andresson T, Naranbhai V, Horowitz A, McMichael AJ, Hoelzemer A, Gillespie GM, Garcia-Beltran WF, Carrington M. Nat Immunol 24 1087-1097 (2023)
- HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder. Boukouaci W, Lajnef M, Richard JR, Wu CL, Bouassida J, Rafik I, Foiselle M, Straczek C, Mezouad E, Naamoune S, Salah S, Bencharif MA, Ben Chaaben A, Barau C, Le Corvoisier P, Leboyer M, Tamouza R. Sci Rep 11 20260 (2021)
- Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models. Ruibal P, Franken KLMC, van Meijgaarden KE, van Wolfswinkel M, Derksen I, Scheeren FA, Janssen GMC, van Veelen PA, Sarfas C, White AD, Sharpe SA, Palmieri F, Petrone L, Goletti D, Abeel T, Ottenhoff THM, Joosten SA. J Immunol 209 1555-1565 (2022)
- Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis. Boukouaci W, Lansiaux P, Lambert NC, Picard C, Clave E, Cras A, Marjanovic Z, Farge D, Tamouza R. Int J Mol Sci 23 7223 (2022)
- The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19. Vietzen H, Furlano PL, Traugott M, Totschnig D, Hoepler W, Strassl R, Zoufaly A, Puchhammer-Stöckl E. J Med Virol 95 e28404 (2023)
- A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening. Vaurs J, Douchin G, Echasserieau K, Oger R, Jouand N, Fortun A, Hesnard L, Croyal M, Pecorari F, Gervois N, Bernardeau K. Sci Rep 11 17234 (2021)
- Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections. Romero-Martín L, Duran-Castells C, Olivella M, Rosás-Umbert M, Ruiz-Riol M, Sanchez J, Hartigan-O Connor D, Mothe B, Olvera À, Brander C. Front Immunol 13 1027855 (2022)
- Effects of HLA single chain trimer design on peptide presentation and stability. Finton KAK, Rupert PB, Friend DJ, Dinca A, Lovelace ES, Buerger M, Rusnac DV, Foote-McNabb U, Chour W, Heath JR, Campbell JS, Pierce RH, Strong RK. Front Immunol 14 1170462 (2023)
- Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Wagner B, Dührsen U, Hüttmann A, Nückel H, Michita RT, Rohn H, Schramm S, Horn PA, Rebmann V. Cancers (Basel) 12 E3429 (2020)
- HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease. Hosseini E, Minagar A, Ghasemzadeh M, Arabkhazaeli A, Ghasemzadeh A. Hum Immunol 84 263-271 (2023)
- High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation. Huisman BD, Guan N, Rückert T, Garner L, Singh NK, McMichael AJ, Gillespie GM, Romagnani C, Birnbaum ME. Nat Commun 14 4809 (2023)
- Intracellular trafficking of HLA-E and its regulation. He W, Gea-Mallorquí E, Colin-York H, Fritzsche M, Gillespie GM, Brackenridge S, Borrow P, McMichael AJ. J Exp Med 220 e20221941 (2023)
- Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance. Shirane M, Yawata N, Motooka D, Shibata K, Khor SS, Omae Y, Kaburaki T, Yanai R, Mashimo H, Yamana S, Ito T, Hayashida A, Mori Y, Numata A, Murakami Y, Fujiwara K, Ohguro N, Hosogai M, Akiyama M, Hasegawa E, Paley M, Takeda A, Maenaka K, Akashi K, Yokoyama WM, Tokunaga K, Yawata M, Sonoda KH. Front Immunol 13 1008220 (2022)
- Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma. Xu YF, Du XF, Li ZY, Fang ZP, Zhang FB. J Int Med Res 49 3000605211047278 (2021)
- Oyez, Oyez, Oyez! Saunders PM, Brooks AG, Rossjohn J. Nat Immunol 24 1052-1053 (2023)
- Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells. Rousselière A, Charreau B. Cells 12 889 (2023)
- The complex HLA-E-nonapeptide in Behçet disease. Castaño-Núñez ÁL, Montes-Cano MA, García-Lozano JR, Ortego-Centeno N, García-Hernández FJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Gómez de la Torre R, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF. Front Immunol 14 1080047 (2023)